AstraZeneca PLC Files Form 6-K

Ticker: AZN · Form: 6-K · Filed: May 1, 2025 · CIK: 901832

Astrazeneca PLC 6-K Filing Summary
FieldDetail
CompanyAstrazeneca PLC (AZN)
Form Type6-K
Filed DateMay 1, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, foreign-issuer, routine-report

Related Tickers: AZN

TL;DR

AZN filed a 6-K, confirming 20-F annual reports. Standard procedure.

AI Summary

AstraZeneca PLC filed a Form 6-K on May 1, 2025, reporting as a foreign issuer. The filing indicates that AstraZeneca is submitting its annual reports under Form 20-F. The company's principal executive offices are located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.

Why It Matters

This filing is a routine report for foreign issuers, providing an update on AstraZeneca's reporting status and corporate information to the SEC.

Risk Assessment

Risk Level: low — This is a routine administrative filing and does not contain new material financial or operational information.

Key Players & Entities

  • AstraZeneca PLC (company) — Filer of the report
  • 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom (location) — Company's principal executive offices
  • May 1, 2025 (date) — Filing date
  • Form 6-K (document) — Type of SEC filing
  • Form 20-F (document) — Annual report form for foreign issuers

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign issuer required by the SEC, used to furnish information which the registrant may be required to publish, file or distribute among its security holders under the laws of the country of its incorporation or organization or the country in which it has its principal or material operations.

Which annual report form does AstraZeneca PLC file?

AstraZeneca PLC files its annual reports under cover of Form 20-F.

When was this Form 6-K filed?

This Form 6-K was filed on May 1, 2025.

Where are AstraZeneca PLC's principal executive offices located?

AstraZeneca PLC's principal executive offices are located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.

What is the Commission File Number for AstraZeneca PLC?

The Commission File Number for AstraZeneca PLC is 001-11960.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on May 1, 2025 regarding ASTRAZENECA PLC (AZN).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.